Results 251 to 260 of about 473,693 (291)

Comparator-Dependent Safety Signals for Incident Systemic Autoimmune Rheumatic Diseases After mRNA COVID-19 Vaccination: A Systematic Review. [PDF]

Vaccines (Basel)
Pinte L, Balanescu P, Dima A, Mandescu AM, Simion-Stanciu ME, Dumitru AC, Baicus C.   +6 more
europepmc   +1 more source

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine, 2022
Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring. Data are needed on the serial use of homologous boosters (same as the primary vaccine) and heterologous boosters (different from the primary vaccine) in ...
Christina A Rostad, Kathleen Neuzil, Robert L Atmar   +2 more
exaly   +3 more sources

Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population

Vaccines
Background: Vaccination has played a crucial role in mitigating the spread of COVID-19 and reducing its severe outcomes. While over 90% of Bangladesh’s population has received at least one COVID-19 vaccine dose, the comparative effectiveness of ...
Mansura Khanam, Md Khaledul Hasan, Kazi Istiaque Sanin   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Shared sugars – parasite glycan homology in HIV-1 vaccine design

Trends in Parasitology, 2022
Immune tolerance to self-glycans is a host mechanism to avoid autoimmunity, which is exploited by HIV-1 coating its envelope glycoproteins with glycans to evade neutralising antibodies (nAbs). Huettner et al. describe cross-reactivity between Schistosoma mansoni glycans and HIV-1 envelope glycoprotein glycans, suggesting a strategy for induction of HIV-
Lachlan P. Deimel, Quentin J. Sattentau
openaire   +2 more sources

Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules

Anti-Cancer Drugs, 2002
This review summarizes and discusses a new vaccine strategy based on xenogeneic homologous molecules by the breaking of immune tolerance against the growth factors or their receptors associated with tumor growth in a cross-reaction between the xenogeneic homologs and self-molecules. The xenogeneic vaccine may circumvent the fact that few tumor-specific
openaire   +2 more sources

Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease

Vaccine, 2009
Rotavirus-like particles (VLPs) have shown promise as rotavirus vaccine candidates in mice, rabbits and pigs. In pigs, VLP vaccines reduced rotavirus shedding and disease but only when used in conjunction with live attenuated human rotavirus. Using a porcine rotavirus pig model, rotavirus antigen shedding was reduced by up to 40% after vaccination with
El-Attar, Laila, Oliver, S.L., Mackie, Alan, Charpilienne, Annie, Poncet, Didier, Cohen, Jean, Bridger, J.C.   +6 more
openaire   +3 more sources